The Impact of Angiotensin II Receptor Blocker Use in Patients with Prostate Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2013, v. 3, n. 4, p. 20
- By:
- Publication type:
- Article
Works matching IS 21641153 AND DT 2013 AND VI 3 AND IP 4
Results: 7
1
2
Recent Cancer Drugs Approved by the FDA.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2013, v. 3, n. 4, p. 17
- Publication type:
- Article
3
Omacetaxine Mepesuccinate: A Novel mRNA Translation Inhibitor for Drug-Resistant Chronic Myelogenous Leukemia.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2013, v. 3, n. 4, p. 6
- By:
- Publication type:
- Article
4
Long-Term Treatment with Cetuximab Linked to Early Tumor Shrinkage in Patients with Colorectal Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2013, v. 3, n. 4, p. 4
- Publication type:
- Article
5
Gemcitabine Increases Survival for Patients with Resected Pancreatic Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2013, v. 3, n. 4, p. 3
- Publication type:
- Article
6
Denosumab Improves Bone Metastasis-Free Survival in Patients with Nonmetastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2013, v. 3, n. 4, p. 2
- Publication type:
- Article
7
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2013, v. 3, n. 4, p. 1
- Publication type:
- Article